The UMass Boston - Dana-Farber/Harvard Cancer Center

U54 CANCER RESEARCH PARTNERSHIP

Partnership Success

  • The U54 Partnership has leveraged 32.7M in research awards, Massachusetts Life Science Initiative committed a $10M earmark grant in 2009 toward the development of the Center for Personalized Cancer Therapy, which was completed in the Spring of 2015.

Faculty Recruitment:

  • 33 faculty members from UMass Boston are associate members of the DF/HCC; and a number of junior and senior faculty members have been recruited, including the joint recruitment of nursing faculty at UMass Boston: Mary Cooley.
  • UMass Boston has made significant progress in recruiting faculty who are involved in cancer and cancer health disparities. In the U54 competing application submitted in 2010, UMass Boston made a commitment to hire the Brann Endowed Chair, plus 9-11 faculty in cancer-related areas. The Brann Endowed Chair and Director of the Center for Personalized Cancer Therapy (CPCT) was hired in 2013; and since 2010, a total of 17 new faculty hires in the areas of cancer and cancer health disparities have been made. 

Capital Development:

  • In the next few years UMass Boston will be pursuing mechanisms to fund the construction of a second Integrative Science Building.

Research Publications:

  • Investigators published over 171 research papers related to partnership projects. Publications were done jointly amongst PIs or independently.

Academic Program Development:

  • An accelerated Nursing PhD program in nursing, cancer and health disparities has been developed at UMass Boston.

Student Involvement/Training:

  • More than 202 UMass Boston students participated in and received cancer-related training from the U56 and U54 Mechanisms.